SOLVE Research & Consultancy
Private Company
Funding information not available
Overview
SOLVE Research & Consultancy operates as a specialized contract research organization (CRO) focused on high-resolution analytical services for the biopharmaceutical and nanotechnology sectors. Its core expertise lies in sophisticated separation and characterization techniques, particularly FFF-MALS, which it claims to be the world's leading contract lab for. The company provides essential support for drug development, formulation, and quality control, helping clients characterize complex samples like proteins, antibodies, viruses, and nanomedicines. By offering consulting and method development alongside analysis, SOLVE positions itself as a scientific partner rather than just a service provider.
Technology Platform
Expert application of advanced biophysical characterization techniques including Field-Flow Fractionation (FFF), Multi-Angle Light Scattering (MALS), Size-Exclusion Chromatography (SEC), Analytical Ultracentrifugation (AUC), and Dynamic Light Scattering (DLS). Specializes in coupling these techniques (e.g., FFF-MALS, SEC-MALS) and pioneering novel on-line couplings like FFF to Small-Angle X-ray Scattering (SAXS) for comprehensive analysis of proteins and nanoparticles in complex matrices.
Opportunities
Risk Factors
Competitive Landscape
SOLVE competes in the niche market for high-end biophysical characterization. Competitors include other specialist CROs focusing on techniques like AUC or light scattering, as well as the analytical services divisions of large, global CROs. Its main differentiation is its claimed leadership in FFF-MALS contract services and its proven ability to develop and apply cutting-edge, multi-technique couplings that many labs cannot offer.